期刊文献+

复方醋酸环丙孕酮与二甲双胍干预对改善多囊卵巢综合征内分泌影响 被引量:42

Influence of cyproterone acetate and metformin on endocrine and metabolism in women with polycystic ovary syndrome
下载PDF
导出
摘要 目的观察复方醋酸环丙孕酮联合二甲双胍对多囊卵巢综合征(PCOS)患者内分泌及代谢的影响。方法将87例PCOS合并胰岛素抵抗(IR)患者随机分成观察组(47例)和对照组(40例),对照组患者给予复方醋酸环丙孕酮治疗,观察组给予复方醋酸环丙孕酮和二甲双胍联合治疗,观察治疗前后血清生殖激素、血糖、血脂水平变化。结果两组患者经过治疗后黄体生成素(LH)、LH与卵泡刺激素(FSH)比值、睾酮(T)和游离雄激素指数(FAI)均较治疗前明显下降(P<0.05),性激素结合球蛋白(SHBG)明显升高(P<0.05),但组间比较观察组变化更显著(P<0.05)。治疗后患者血清高密度脂蛋白胆固醇(HDL-C)升高(P<0.05),低密度脂蛋白胆固醇(LDL-C)降低(P<0.05),而观察组变化更明显(P<0.05),其他指标治疗前、后无变化(P>0.05)。结论二甲双胍与复方环丙孕酮联合应用治疗PCOS,较单纯应用复方环丙孕酮能更有效改善IR及高雄激素血症,值得临床推广应用。 Objective To observe the influence of cyproterone acetate(CPA) and metformin on endocrine and metabolism in women with polycystic ovary syndrome(PCOS).Methods A total of 87 women with PCOS were enrolled and randomly allocated into observed group(47 cases) and control group(40 cases),patients in control group were treated by CPA,while others were treated by CPA and metformin,and the endocrine,metabolism and ovulation were assessed initially and treatment in two groups.Results LH,LH/FSH value,T and FAI significantly reduced(P0.05),but the SHBG significantly improved(P0.05),and there was a significant difference between the two groups(P0.05).After treatment the level of serum HDL-C increased and the level of LDL-C decreased(P0.05).Conclusion The PCOS patients treated with metformin in combination with CPA may be more effective in improved their endocrine and metabolism than CPA alone.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第36期3807-3808,3811,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81100402)
关键词 多囊卵巢综合征 二甲双胍 胰岛素抵抗 复方醋酸环丙孕酮 polycystic ovary syndrome metformin insulin resistance compound cyproterone acetate
  • 相关文献

参考文献10

二级参考文献77

  • 1金博弘,周馥贞.多囊卵巢综合征的诊断标准[J].国外医学(计划生育分册),2005,24(3):152-154. 被引量:17
  • 2张以文.多囊卵巢综合征研究的新进展[J].国外医学(妇产科学分册),1995,22(2):67-70. 被引量:17
  • 3郑建淮,曹缵孙,任娟.罗格列酮和二甲双胍治疗多囊卵巢综合征患者的临床疗效比较[J].实用妇产科杂志,2005,21(9):541-544. 被引量:8
  • 4陈军建,王东,俞力,杨玲.罗格列酮和二甲双胍联合治疗多囊卵巢综合征临床观察[J].中国现代医药杂志,2007,9(4):16-18. 被引量:4
  • 5The Rotterdam ESHRE /ASRM - Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome (PCOS) [J]. Hum Reprod, 2004, 19 (1): 41- 47.
  • 6Azziz R, Carmina E, DewaillyD, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline [J]. J Clin Endocrinol Metab, 2006, 91 (11) : 4237-4245.
  • 7Trader BC, Pall M, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in a group of women presenting with oligomenorrhea or Hirsutism: NIH 1990 vs. Rotterdam 2003 Criteria [C]. The 88th Annual Meeting of The Endocrine Society, Boston, MA, 2006: 2-601.
  • 8Ibanez L, Dimartino-Nardi J, Potau N, et al. Premature adren arche-normal variant or forerunner of adult disease? [J]. Endocr Rev, 2000, 21 (6): 671-696.
  • 9Unluhizarci K, Ozocak M, TanriverdiF, et al. Investigation of hypothalamo- pituitary -gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystie ovary syndrome [J].Fertil Steril, 2007, 87 (6): 1377-1382.
  • 10Leibel NI, Baumann EE, Kochergin sky M, et al. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome [J]. J Clin Endocrinol Metab,2006, 91 (4): 1275-1283.

共引文献55

同被引文献246

引证文献42

二级引证文献353

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部